Lactoferrin
Lactoferrin (bovine, bLf; human, hLf)
Lactoferrin is an iron-binding immune protein from milk with good evidence for improving iron status in pregnancy as an alternative to iron salts, mixed evidence for preventing sepsis in preterm infants, and preliminary evidence for infections, acne and gut health.
At a Glance
- Best known for
- Raises hemoglobin and ferritin in iron-deficient pregnant women with fewer GI side effects than ferrous sulfate, Broad antimicrobial activity (bacteria, viruses, fungi) by iron sequestration and membrane disruption, Reduced late-onset sepsis in preterm infants in some trials (not in the largest)
- Evidence
- Moderate
- Typical dose
- 100 mg bovine lactoferrin 2x daily before meals
- Type
- Compound
What is Lactoferrin?
Lactoferrin is an iron-binding glycoprotein of the transferrin family found in milk (especially colostrum, where it is the dominant whey protein), tears, saliva, nasal secretions and the granules of neutrophil white blood cells. It is a frontline defense molecule, binding iron so tightly that it starves bacteria of this essential nutrient, while also directly damaging microbial membranes and modulating immune responses. Bovine lactoferrin purified from cow's milk is sold as a supplement, added to infant formula to mimic human milk, and studied as an iron supplement that works differently from iron salts. Human lactoferrin produced in rice or yeast is used in research. It is one of the most studied milk proteins, with over 10,000 publications.
Known Health Benefits
How It Works
Lactoferrin's two iron-binding sites hold ferric iron with an affinity 300 times greater than transferrin, depriving iron-dependent bacteria of growth and disrupting biofilms. Its positively charged N-terminal region and the peptide lactoferricin, released by pepsin digestion, bind lipopolysaccharide and bacterial membranes, causing direct bactericidal effects, and block viral attachment to cell-surface heparan sulfate, explaining in-vitro activity against herpes, hepatitis C, rotavirus, RSV and SARS-CoV-2. For iron status, lactoferrin appears to work by binding to intestinal lactoferrin receptors and by reducing IL-6-driven hepcidin, the hormone that locks iron in storage during inflammation; this frees iron for red cell production without the oxidative stress and GI irritation of iron salts. Lactoferrin also promotes bifidobacteria growth, enhances natural killer cell and neutrophil activity, reduces pro-inflammatory cytokines, and promotes bone-forming osteoblast activity in cell studies.
What Research Says
The strongest adult evidence is in pregnancy anemia: multiple Italian randomized trials from the Paesano and Valenti group found 100 mg bovine lactoferrin twice daily raised hemoglobin and serum iron more effectively than ferrous sulfate, with far fewer GI side effects, and lowered IL-6 and hepcidin; a 2020 meta-analysis of pregnancy trials supported lactoferrin's superiority on hemoglobin and tolerability, though most trials come from the same group. In preterm infants, a 2020 Cochrane review found lactoferrin reduced late-onset sepsis and necrotizing enterocolitis across small trials, but the large UK ELFIN trial of 2,203 infants (2019) found no benefit, leaving the question unresolved. A randomized trial of 36 adults with acne found lactoferrin-enriched milk reduced inflammatory lesions by 38% over 12 weeks. Small trials show reduced neonatal and childhood infections, faster H. pylori eradication when added to triple therapy (meta-analysis), and improved hepatitis C responses that did not hold in larger studies. COVID-19 trials were small and inconclusive. Overall: moderate evidence for iron status, inconsistent for sepsis prevention, preliminary elsewhere.
Active Compounds
Lactoferrin glycoprotein (80 kDa, two iron-binding lobes); lactoferricin and lactoferrampin (peptides released by digestion); apo- (iron-free) and holo- (iron-saturated) forms
Forms & Bioavailability
Oral lactoferrin is partially digested in the stomach, but a meaningful portion survives (more in infants, whose stomachs are less acidic, and in adults when taken with food or enteric-coated). Fragments such as lactoferricin retain antimicrobial activity, and intact lactoferrin binds receptors on intestinal cells and is detectable in small amounts in blood. Apo-lactoferrin (iron-free) has stronger antimicrobial action, while native lactoferrin is about 15–20% iron-saturated. Iron-status effects appear over 4–8 weeks. Heat processing above 70°C denatures lactoferrin, so quality products use low-temperature purification.
Dosage Guidance
| Use Case | Dosage |
|---|---|
| Iron deficiency in pregnancy | 100 mg bovine lactoferrin 2x daily before meals |
| Iron deficiency (non-pregnant adults) | 200–250 mg daily, with or without low-dose iron |
| Immune / infection support | 200–600 mg daily |
| Acne (adjunct) | 200 mg daily for 12 weeks |
| Preterm infant sepsis prevention | 100–200 mg daily (NICU use only) |
Always consult a healthcare provider for personalized dosing.
Natural Food Sources
- Human breast milk (highest, especially colostrum)
- Cow's milk (low; 0.1–0.3 g/L; higher in colostrum)
- Whey protein (trace amounts)
- Lactoferrin-fortified infant formulas
- Not obtainable in supplemental amounts from ordinary diet
Potential Side Effects
Very well tolerated; occasional constipation, loss of appetite, nausea or skin rash at higher doses; contains trace milk protein (caution in milk allergy); no serious adverse effects in trials up to 3 g daily
Who Should Avoid It
- Cow's milk protein allergy (trace casein/whey may remain)
- Iron overload disorders (hemochromatosis) — lactoferrin may enhance iron absorption from food
- Preterm infants outside a clinical protocol
- Known hypersensitivity to lactoferrin products
Pregnancy & Lactation
Bovine lactoferrin has been given to pregnant women in several randomized trials at 200 mg daily for up to 3 months with excellent tolerability and no fetal or maternal safety concerns, and it is studied specifically as a pregnancy iron supplement. It is a natural component of breast milk, and bovine lactoferrin is added to many infant formulas with regulatory approval. Supplement use during breastfeeding is considered safe.
Known Drug Interactions
May reduce effect of some antibiotics by altering iron availability (theoretical); may enhance antibiotic action against biofilm bacteria; no significant interactions documented; separate from iron supplements only if advised, since lactoferrin can be given with iron
Evidence Classification
Supported by cohort studies, case-control studies, or multiple observational studies with consistent findings.
Frequently Asked Questions
Can lactoferrin replace iron tablets for anemia?
In pregnancy trials it raised hemoglobin at least as well as ferrous sulfate with far fewer digestive side effects, apparently by lowering the hormone hepcidin and releasing stored iron rather than by supplying much iron itself. It works best when iron stores exist but are locked up by inflammation; in severe depletion, some iron intake is still needed. It is a reasonable option for people who cannot tolerate iron salts, ideally with ferritin monitoring.
Does lactoferrin protect against viruses like COVID-19 or the flu?
Lactoferrin blocks many viruses from attaching to cells in the laboratory, including coronaviruses, and some small observational and pilot studies during the pandemic reported faster recovery, but randomized trials were small and did not establish benefit. It is a plausible, low-risk immune-support supplement, not a proven antiviral.
Is apo-lactoferrin or regular lactoferrin better?
Apo-lactoferrin (iron-stripped) has the strongest iron-sequestering antimicrobial activity and is favored for infection and gut support. Native bovine lactoferrin (about 15–20% saturated) was used in the pregnancy anemia trials. For most purposes the difference is minor; the trial-matched form is a sensible choice for a specific goal.
Why did the big preterm infant trial find no benefit?
Several small trials suggested lactoferrin cut sepsis and necrotizing enterocolitis in preterm babies, but the 2,203-infant ELFIN trial in the UK found no reduction. Possible explanations include differences in the lactoferrin product, dose, baseline infection rates and probiotics use. The question is open, and lactoferrin for preterm infants remains a research intervention rather than standard care.
References
- Lactoferrin: A Natural Glycoprotein Involved in Iron and Inflammatory Homeostasis. Rosa L, Cutone A, Lepanto MS, Paesano R, Valenti P. Int J Mol Sci (2017)
- Oral administration of lactoferrin increases hemoglobin and total serum iron in pregnant women. Paesano R, Torcia F, Berlutti F, et al.. Biochem Cell Biol (2006)
- Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants. Pammi M, Suresh G. Cochrane Database Syst Rev (2020)
- Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial (ELFIN). ELFIN trial investigators group. Lancet (2019)
Related Health Conditions
Related Supplements
Have questions about Lactoferrin?
Ask Mother Nature AI about dosing, interactions with your medications, whether it fits your health goals, and more — personalized to your health profile.
This entry is for educational purposes only. It is not medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement regimen, especially if you take medications or have health conditions.